Trial intelligence / Profile preview

Compound Solidago virgaurea Spray in Pediatric Acute Pharyngitis

CTR20220061Phase 2Completed

Sponsor
Guizhou Bailing Group Pharmaceutical Co., Ltd.
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Compound Solidago Spray in acute pharyngitis, sponsored by Guizhou Bailing Group Pharmaceutical Co., Ltd.. Started Jan 2022; status: completed.

02

Drugs

Compound Solidago Spray
03

Conditions

acute pharyngitis

Beyond the preview

Go deeper on CTR20220061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20220061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call